Pinsent Masons LLP regularly handles complex patent disputes for clients and has accrued impressive experience and knowledge regarding UPC litigation and rules. The team is led by Jules Fabre, who has a strong specialism in life sciences and pharmaceuticals and also handles SPC litigations and coordination of pan-European patent litigation. Marina Jonon is key to the firm and leverages her previous experience in national firms; in addition to supporting with litigation, she advises on regulatory issues in the healthcare sector. Emmanuel Gougé left the firm in 2024.
Testimonials
Collated independently by Legal 500 research team.
‘Excellent knowledge of local law and practice, availability, counsel on litigation, patent invalidation and on practical and strategic aspects linked to the French law.’
‘Jules Fabre, Marina Jonon: in addition to their outstanding knowledge of the technical area and of local law, they have provided advice in a timely and clear manner, with strategic outlook and full discussion of the possible scenarios, and achieved a major victory in a pharma patent action being litigated across Europe. ’
Key clients
- Advanced Cell Diagnostics
- Formycon
Work highlights
- Representing Zentiva in the context of an application for a fast-track preliminary injunction from Bayer against the contemplated launch of Zentiva’s generic rivaroxaban (Xarelto) product in France, on the basis of alleged infringement of a patent covering once-daily administration of rivaroxaban.
- Assisting Advanced Cell Diagnostics with the preparation and filing of a UPC infringement action against one of its main competitors in relation to kits for multiplexed, quantitative, high-resolution bioimaging in academic research, drug development, and clinical pathology and diagnostics.